Skip to main content

Arine

Category: AI in Healthcare

Arine is an AI-driven medication intelligence platform that optimizes medication management for health plans and providers to improve patient outcomes and reduce costs. Arine was founded in 2017. The company is led by Yoona Kim. Based in San Francisco, USA. Team size: 51-200. Total funding raised: $66 million. Latest round: Series C ($30M, Jun 2025 led by Town Hall Ventures, Kaiser Permanente). Key investors include ["Town Hall Ventures","Kaiser Permanente Ventures","New Leaf Venture Partners","MBX Capital","SCAN Group"].

Founded
2017
Headquarters
San Francisco, USA
Team size
51-200
Total funding
$66 million

Value proposition

To optimize medication therapy and treatment plans by ensuring each patient is on the safest, most effective, and most appropriate therapy for their unique needs, ultimately reducing healthcare costs and improving clinical outcomes.

Products and solutions

["Elevate (Medication Therapy Management - MTM)","Luminate (High-Risk Patient Management)"]

Unique value

Arine's platform is unique in its ability to ingest and analyze a wide array of real-world data—including medical records, pharmacy claims, and social determinants of health—in real-time. It uses this data to generate personalized, evidence-based recommendations and care plans, shifting from reactive to proactive medication management.

Target customer

Health plans, providers, and healthcare organizations.

Industries served

["Healthcare","Health Insurance"]

Technology advantage

The company's key advantage is its proprietary AI-powered platform, referred to as 'Medication Intelligence.' This technology combines data science with deep clinical expertise to continuously monitor and optimize treatment plans at a population scale, identifying at-risk patients and suggesting interventions to prevent adverse drug events and improve medication adherence.

How they differentiate

Arine differentiates itself through its AI-driven medication intelligence platform, which provides personalized medication recommendations to improve patient outcomes and reduce healthcare costs. The company focuses on delivering value-based outcomes and comprehensive medication management.

Main competitors

["CoverMyMeds","Myriad Neuroscience","MEDdelivery"]

Key partnerships

["Priority Health","Blue Shield of California","California Right Meds Collaborative (USC School of Pharmacy)"]

Notable customers

["Priority Health","Blue Shield of California","SCAN Group"]

Major milestones

["Secured $29 million in Series B funding in August 2022.","Named to the Inc. 5000 list of fastest-growing private companies.","Co-founders Yoona Kim and Penjit Moorhead were named to the Inc. Female Founders 500 list.","Achieved HITRUST Risk-Based, 2-year (r2) Certification for its Arine Portal.","Raised $30 million in a Series C funding round led by Town Hall Ventures."]

Growth metrics

Arine was recognized as one of America's fastest-growing private companies on the Inc. 5000 list. The company reports a 100% client retention rate and has touched more than 20 million lives, producing over 40 million recommendations annually.

Market positioning

Arine is positioned as a technology leader in the medication management space, offering a SaaS platform to optimize medication therapy for healthcare organizations like health plans and providers. Its focus on AI and data analytics places it at the forefront of healthcare innovation.

Geographic focus

USA

Patents and IP

Specific patent information is not publicly available. The company's intellectual property lies in its proprietary AI algorithms, data analytics platform, and clinical workflows.

About Yoona Kim

Health Economist, Pharmacist, and former Head of Clinical Modeling and Analytics at Proteus Digital Health

Official website: